Page last updated: 2024-10-30

metformin and Blood Coagulation Factor Deficiencies

metformin has been researched along with Blood Coagulation Factor Deficiencies in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
" Long-term use of OCPs needs to be considered carefully for PCOS patients who are already burdened with associated risk factors."1.51Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study. ( Amin, S; Bhat, IA; Fatima, Q; Ganie, MA; Jeelani, H; Kawa, IA; Manzoor, S; Rashid, F; Shah, ZA; Yousuf, SD, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Manzoor, S1
Ganie, MA1
Amin, S1
Shah, ZA1
Bhat, IA1
Yousuf, SD1
Jeelani, H1
Kawa, IA1
Fatima, Q1
Rashid, F1

Other Studies

1 other study available for metformin and Blood Coagulation Factor Deficiencies

ArticleYear
Oral contraceptive use increases risk of inflammatory and coagulatory disorders in women with Polycystic Ovarian Syndrome: An observational study.
    Scientific reports, 2019, 07-15, Volume: 9, Issue:1

    Topics: Adult; Body Mass Index; Coagulation Protein Disorders; Contraceptives, Oral; Ethinyl Estradiol; Fema

2019